Reply to Maase et al. Comment on "Jones et al. Application of a Novel Algorithm for Expanding Newborn Screening for Inherited Metabolic Disorders across Europe. Int. J. Neonatal Screen. 2022, 8, 20"

Int J Neonatal Screen. 2023 Feb 16;9(1):8. doi: 10.3390/ijns9010008.

¹ Willink Biochemical Genetics Unit, Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, St Mary's Hospital, Oxford Road, Manchester M13 9WL, UK.
² Service Biochimie et Biologie Moléculaire, Groupement Hospitalier Est, Hospices Civils de Lyon, 69002 Lyon, France.
³ Department of Metabolic Medicine, Great Ormond Street Hospital NHS Foundation Trust, London WC1N 3JH, UK.
⁴ Neurometabolic Unit, University College London Hospitals NHS Foundation Trust and Enzymes Laboratory, Great Ormond Street Hospital NHS Foundation Trust, London WC1N 3JH, UK.
⁵ ArchAngel MLD Trust, Registered Charity No. 1157825, London W2 1DT, UK.
⁶ Helvet Health, Ruelle de la Muraz 4, 1260 Nyon, Switzerland.
⁷ Division of Inherited Metabolic Diseases, Reference Centre Expanded Newborn Screening, University Hospital Padova, 35128 Padova, Italy.

Abstract

The commentary provided by Maase et al. [...].